Chiron Plans To Pay £542 Million In Cash To Acquire PowderJect May 21, 2003 By Nuala Moran LONDON - Chiron Corp. plans to acquire PowderJect Pharmaceuticals plc in an agreed-to cash offer valuing the vaccines manufacturer at £542 million (US$878 million). (BioWorld International)Read More
